APVO
Aptevo Therapeutics Inc
stockNASDAQ
aptevo therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. we leverage the innovative adaptir™ platform technology, a unique approach to cancer immunotherapy, to improve outcomes for cancer patients. based in seattle, washington, the company is proud of its empowering work environment, entrepreneurial culture, and proprietary platform technology. as a result, aptevo has been able to attract some of the most innovative minds in the field. many of our team members have notable experience with other pioneering biotech companies including trubion, zymogenetics, immunex, dendreon, and vlst. at aptevo therapeutics, our core values of ownership and collaboration—combined with a history of innovation, dedication, and development—are positioning aptevo therapeutics to develop the science of what's next in biotechnology.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 1.61 | 2026-10-22 | -14.91% | -7.776 |
| 1M | 1.86 | 2026-09-29 | -26.34% | -0.841 |
| 3M | 3.98 | 2026-07-29 | -65.58% | -0.670 |
| 6M | 4.81 | 2026-04-29 | -71.52% | -0.262 |
| 1Y | 25.56 | 2025-10-29 | -94.64% | 1.037 |
| 2Y | 4,049.28 | 2024-10-29 | -99.97% | — |
| 5Y | 8,931,859.20 | 2021-10-29 | -100.00% | 0.966 |
Aptevo Therapeutics Inc (NASDAQ:APVO) stock price today is $1.37, and today's volume is 58,514. APVO is up 5.385% today. The 30 day average volume is 53,423. APVO market cap is $2.48M with 1.81M shares outstanding.